Finasteride

Overview

Finasteride is a medication primarily used to treat benign prostatic hyperplasia (BPH) and male pattern hair loss (androgenetic alopecia) in men.¹² It is classified as a 5α-reductase inhibitor, an antiandrogen that reduces the production of dihydrotestosterone (DHT), a hormone responsible for prostate enlargement and hair follicle miniaturization.¹⁴ Sold under brand names like Proscar (5 mg for BPH) and Propecia (1 mg for hair loss), it was first approved by the FDA in 1992 for BPH and in 1998 for hair loss.⁴⁶ Finasteride works by decreasing DHT levels by about 70%, leading to reduced prostate volume and improved urinary symptoms or hair regrowth.¹³ It is also used off-label for hirsutism in women.³⁶ Available only by prescription, it requires ongoing use as effects reverse upon discontinuation.⁶⁷

Forms and Variations

Finasteride is primarily available as oral tablets in two main strengths: 5 mg (Proscar or generic for BPH) and 1 mg (Propecia or generic for hair loss).¹³ Topical formulations exist for hair loss to minimize systemic absorption and target scalp follicles directly.¹ Combination products like Entadfi (finasteride with tadalafil) are used for BPH symptoms.⁴ Generic versions are widely available and cost-effective compared to brands.¹ Choose 5 mg for prostate issues as it reduces prostate volume by 20-30%; opt for 1 mg for hair loss on the vertex and mid-scalp.¹³ Topical forms may suit those concerned about sexual side effects from oral use.¹ All forms inhibit type II 5α-reductase, but oral provides systemic DHT reduction.⁴

Dosage and Administration

For BPH, the standard dose is 5 mg orally once daily.³⁴ For male pattern hair loss, take 1 mg orally once daily.³⁶ Effects on BPH appear in 3-6 months; hair regrowth may take longer.³ For hirsutism in women, 5 mg daily with or without oral contraceptives.³ Take with or without food; consistent daily use is key as DHT reduction lasts 24 hours per dose.³ Swallow tablets whole; do not crush or chew.⁷ Topical applications follow product instructions for scalp use.¹ Monitor PSA levels during BPH treatment as finasteride lowers them by about 50%.¹ Discontinue if planning conception, as it affects sperm parameters reversibly.¹

Scientific Research and Mechanism of Action

Finasteride competitively inhibits type II and III 5α-reductase enzymes, preventing conversion of testosterone to DHT in prostate, scalp, and skin.¹⁴⁶ A single 5 mg dose reduces serum DHT by 70% within 8 hours, sustaining for 24 hours.³ In BPH, it shrinks prostate by 20-30%, improving urinary flow and reducing retention risk.¹² For hair loss, scalp DHT drops 66%, promoting follicle recovery.⁵ Long-term studies like the Prostate Cancer Prevention Trial showed reduced low-grade prostate cancer risk but potential high-grade increase.⁶ It also inhibits neurosteroids like allopregnanolone.¹ Research confirms efficacy in men; women"s hirsutism response varies.³ Effects reverse 14 days post-discontinuation.⁶ Current evidence supports use under medical supervision due to side effect profiles.⁶

Benefits and Potential Uses

Proven benefits include symptom relief in BPH: reduced frequent urination, improved flow, lower acute urinary retention risk, and delayed surgery need.²⁴ For male pattern hair loss, it halts progression and promotes regrowth in vertex/mid-scalp areas in mild-moderate cases.³⁶ Reduces prostate volume and PSA levels, aiding BPH management.¹ Off-label, it treats hirsutism in women, especially mild cases, often with contraceptives.³⁶ Potential uses extend to hyperandrogenism symptoms.⁶ Long-term use lowers overall prostate cancer risk in some studies, though monitoring is essential.⁶ Improves quality of life by addressing urinary hesitancy and hair thinning.⁷

Side Effects and Risks

Common side effects include decreased libido, erectile dysfunction, and ejaculation disorders (1-2% incidence, often reversible).¹ Breast tenderness/enlargement or gynecomastia may occur.⁷ Rare persistent effects (post-finasteride syndrome) reported but debated.¹ Risks include potential increased high-grade prostate cancer detection.⁶ Affects sperm motility/count reversibly.¹ Women risk birth defects if handling crushed tablets (pregnancy category X).² Use caution in liver disease; mood changes or depression possible.¹ Not for women of childbearing age.⁶

Interactions and Precautions

No major drug interactions, but caution with other prostate cancer screenings as it lowers PSA.¹ May enhance effects of antihypertensives like doxazosin for BPH.²⁴ Avoid in pregnancy; women should not handle tablets.² Precautions for men planning fertility due to semen impacts.¹ Monitor in liver impairment as metabolized hepatically.³ Discuss prostate cancer family history; baseline PSA recommended.⁶ Before surgery, inform providers of use.² Pediatric use not established; not for female hair loss.⁷

Impact on Biomarkers

Finasteride significantly lowers serum DHT by 70% and scalp DHT by 66%.¹⁵ Reduces PSA levels by ~50%, requiring adjusted interpretation for prostate cancer screening.¹ Increases serum testosterone slightly.⁷ Decreases epididymal weight and sperm parameters temporarily.¹ May affect neurosteroid levels like allopregnanolone.¹

Overdose and Toxicity

No specific antidote; overdose symptoms mimic side effects like sexual dysfunction.² Single 400 mg dose caused no abnormalities beyond expected DHT reduction.³ Dialysis ineffective due to high protein binding.³ Safe upper limit aligns with 5 mg daily; higher doses not recommended.³ Seek medical attention for severe symptoms; toxicity low due to fecal/urinary excretion.³

Disclaimer

The information provided in this document is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.